Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Litfulo in Hepatic Impairment
NCT04016077Phase 1Completed
- Sponsor
- Pfizer
- Start
- Jul 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ritlecitinib tosilate in alopecia areata (3 arms), sponsored by Pfizer. Primary endpoints: Area Under the Plasma Concentration-time Profile From Time 0 to 24 Hours and Maximum Plasma Concentration at Day 10. Started Jul 2019; status: completed.
02
Drugs
ritlecitinib tosilate
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT04016077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04016077.